Prof. Wenhui Zhao 赵文辉
Chief Physician, Professor
Department of Medical Oncology (II), Harbin Medical University Cancer Hospital, Harbin
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Medical oncology for breast cancer, malignant lymphoma, lung cancer, and gastrointestinal tumors. Specializes in chemotherapy, endocrine therapy, and biological therapy for breast cancer.
Dr. Zhao holds a medical doctorate and completed postdoctoral training. After graduating from Harbin Medical University in 2001, Dr. Zhao joined the hospital’s breast cancer and lymphoma department. In 2009, Dr. Zhao studied at Yamagata University in Japan. Research focuses on breast cancer metastasis and drug resistance. Dr. Zhao has led national and provincial research projects and received four provincial-level science and technology awards.
Name order: in Chinese the family name comes first (Zhao Wenhui). Papers usually list the name as Wenhui Zhao or Zhao W.
Selected publications
28 papers on PubMed matched by name and affiliation; 13 as first or senior author since 2016. Most recent first- or senior-author papers:
- Front Oncol, 2026 (senior author): Lipid metabolism reprogramming: key mechanism of breast cancer endocrine therapy resistance. PubMed 42798757
- Front Pharmacol, 2026 (senior author): Drug-specific safety signal prioritization of antibody-drug conjugates in breast cancer: integrating FAERS pharmacovigilance, machine learning, and clinical contextualization. PubMed 42780764
- Front Immunol, 2026 (senior author): Cyclin-dependent kinase 4 and 6 inhibitors and the breast cancer immune ecosystem: immune remodeling, resistance, and therapeutic reprogramming. PubMed 42698831
- Front Pharmacol, 2026 (senior author): Comparative safety signal prioritization of CDK4/6 inhibitors in breast cancer: a FAERS pharmacovigilance, machine learning, and clinical contextualization study. PubMed 42688497
- Cell Commun Signal, 2026 (senior author): ADAM12 in a stromal-checkpoint framework: integrating tumor microenvironment remodeling and therapy resistance in solid tumors. PubMed 42902290
- Front Immunol, 2026 (senior author): Breast cancer brain metastasis: from molecular insights to therapeutic innovation. PubMed 41972151
- Front Endocrinol (Lausanne), 2026 (senior author): Global trends and disease burden of elderly male breast cancer, 1990-2021: a population-based study. PubMed 41727696
- Arch Public Health, 2024 (senior author): Global, regional, and national trends in the burden of breast cancer among individuals aged 70 years and older from 1990 to 2021: an analysis based on the global burden of disease study 2021. PubMed 39343976
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion